BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25786478)

  • 21. Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
    Burnham AJ; Armstrong J; Lowen AC; Webster RG; Govorkova EA
    J Virol; 2015 Apr; 89(8):4575-87. PubMed ID: 25673705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.
    Sheu TG; Deyde VM; Garten RJ; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):354-60. PubMed ID: 19887086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
    Ivashchenko AA; Jones JC; Shkil DO; Ivanenkov YA; Pascua PNQ; Penaflor MK; Karapetian RN; Govorkova EA; Ivachtchenko AV
    Antiviral Res; 2023 Sep; 217():105701. PubMed ID: 37567255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
    J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ; McDonough AC; Olson BA; Drusano GL
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
    Hurt AC; Ernest J; Deng YM; Iannello P; Besselaar TG; Birch C; Buchy P; Chittaganpitch M; Chiu SC; Dwyer D; Guigon A; Harrower B; Kei IP; Kok T; Lin C; McPhie K; Mohd A; Olveda R; Panayotou T; Rawlinson W; Scott L; Smith D; D'Souza H; Komadina N; Shaw R; Kelso A; Barr IG
    Antiviral Res; 2009 Jul; 83(1):90-3. PubMed ID: 19501261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies.
    Ilyushina NA; Komatsu TE; Ince WL; Donaldson EF; Lee N; O'Rear JJ; Donnelly RP
    Virol J; 2019 Nov; 16(1):149. PubMed ID: 31783761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan.
    Chong Y; Matsumoto S; Kang D; Ikematsu H
    Influenza Other Respir Viruses; 2019 Mar; 13(2):115-122. PubMed ID: 30548432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
    Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
    Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
    Takashita E; Daniels RS; Fujisaki S; Gregory V; Gubareva LV; Huang W; Hurt AC; Lackenby A; Nguyen HT; Pereyaslov D; Roe M; Samaan M; Subbarao K; Tse H; Wang D; Yen HL; Zhang W; Meijer A
    Antiviral Res; 2020 Mar; 175():104718. PubMed ID: 32004620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y; Baz M; Boivin G
    Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.
    Song MS; Marathe BM; Kumar G; Wong SS; Rubrum A; Zanin M; Choi YK; Webster RG; Govorkova EA; Webby RJ
    J Virol; 2015 Nov; 89(21):10891-900. PubMed ID: 26292325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.
    McKimm-Breschkin JL; Williams J; Barrett S; Jachno K; McDonald M; Mohr PG; Saito T; Tashiro M
    J Antimicrob Chemother; 2013 Oct; 68(10):2210-21. PubMed ID: 23759505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs.
    Correia V; Santos LA; Gíria M; Almeida-Santos MM; Rebelo-de-Andrade H
    J Med Virol; 2015 Jan; 87(1):45-56. PubMed ID: 25042157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
    Huang L; Zhou JF; Wei H; Shu YL
    Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of influenza B viruses with reduced sensitivity to neuraminidase inhibitor in Morocco during 2014/15 season.
    Elfalki F; Ihazmad H; Bimouhen A; Regragui Z; Benkaroum S; Bakri Y; Barakat A
    East Mediterr Health J; 2016 Oct; 22(7):453-459. PubMed ID: 27714739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
    Abed Y; Fage C; Lagüe P; Carbonneau J; Papenburg J; Vinh DC; Boivin G
    Emerg Infect Dis; 2019 Apr; 25(4):838-840. PubMed ID: 30882323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
    Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
    Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
    Mohr PG; Geyer H; McKimm-Breschkin JL
    Antiviral Res; 2011 Jul; 91(1):20-2. PubMed ID: 21549758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.